8 research outputs found

    Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP

    Get PDF
    Cannabinoid receptor 1 (CB1R) controls various physiological and pathological conditions, including memory, motivation, and inflammation, and is thus an interesting target for positron emission tomography (PET). Herein, we report a ruthenium-mediated radiolabeling synthesis and preclinical evaluation of a new CB1R specific radiotracer, [18F]FPATPP. [18F]FPATPP was produced with 16.7 ± 5.7% decay-corrected radiochemical yield and >95 GBq/μmol molar activity. The tracer showed high stability, low defluorination, and high specific binding to CB1Rs in mouse brain.</p

    Reactive Oxygen Species in the Immune System

    No full text

    Copper-mediated late-stage radiofluorination: five years of impact on preclinical and clinical PET imaging

    No full text

    Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-α

    No full text
    corecore